Last updated: May 1, 2026, 5:06 am
PSTU-07 - 42 - Digital twins for medication therapy: Simulation for precision therapy
Tracks
Track 3
| Tuesday, September 1, 2026 |
| 2:30 PM - 4:00 PM |
Details
Organised by the FIP Academic Pharmacy Section in collaboration with the FIP Ethics Advisory Group, the FIP Health and Medicines Information Section and the FIP Technology Advisory Group
Chair(s)
Dr Raj K.S. Badhan, Member of the Communications Committee, the FIP Health and Medicines Information Section, UK & Ms Mansi Doshi, Executive Committee Member, the FIP Academic Pharmacy Section, India
Introduction:
Imagine testing medication dosing regimens in a virtual patient before exposing the real patient to trial-and-error adjustment. One can predict anticoagulation control, forecasting immunosuppressant trough concentrations, antimicrobial dosing, or simulating chemotherapy outcomes based on individual pharmacokinetic and pharmacodynamic parameters.
Digital twin technology, already revolutionising aviation and manufacturing through predictive simulation, is now entering clinical pharmacy through model-informed precision dosing (MIPD). Yet most pharmacists lack familiarity with the methodology, software tools, or governance frameworks needed for responsible implementation.
This session demystifies digital twins for pharmacy, providing foundational understanding of pharmacometrics modelling, practical experience running simplified simulations, and critical guidance on accountability frameworks that ensure simulation-informed decisions enhance rather than replace clinical judgment. Through a detailed pharmacotherapeutic case study and live demonstration, participants will explore how MIPD strengthens precision dosing for medications with narrow therapeutic indices, complex pharmacokinetics, or high inter-patient variability.
Programme:
Learning objectives:
1. Gain understanding of digital twin methodology and model-informed precision dosing applied to high-risk medications.
2. Link the benefits of digital twin-enabled precision dosing to broader system-level outcomes, including patient safety at the population level, interprofessional collaboration, and equitable access to advanced digital health solutions in line with “One Health” Principles.
3. Awareness of governance, accountability, and quality assurance frameworks for simulation-informed decisions.
Take home messages:
This session builds awareness and foundational understanding of digital twins and model-informed precision dosing, enabling pharmacists to engage confidently with these tools, collaborate effectively with interdisciplinary teams, and make informed contributions to their responsible implementation in practice.
FIP Development Goals:
To learn more about these FIP Development Goals, click on the links below.
FIP Development Goal 12: Pharmacy Intelligence
FIP Development Goal 19: Patient Safety
FIP Development Goal 20: Digital Health
| 14:30 – 14:40 | Introduction by the chairs |
| 14:40 – 15:00 | Meet your digital twin, model-informed precision dosing and pharmacy applications |
| Prof. R. Stephanie Huang, Chair, University of Minnesota, USA | |
| 15:00 – 15:20 | From bench to bedside - Model-informed dosing in practice: Case study and workflow integration |
| Dr Cindy Lau, St Vincent’s Hospital, Sydney, Australia | |
| 15:20 – 15:30 | Interactive audience polling |
| 15:30 – 15:50 | Panel discussion with chairs, speakers and additional panellists |
| 15:50 – 16:00 | Closing remarks by the chairs |
Chairs & speakers
Prof Raj Badhan
Associate Professor
Aston University
Chairing of 42 - Digital twins for medication therapy: Simulation for precision therapy
Prof. R. Stephanie Huang
University of Minnesota
Meet your digital twin, model-informed precision dosing and pharmacy applications
Dr Cindy Lau
St Vincent’s Hospital
From bench to bedside - Model-informed dosing in practice: Case study and workflow integration
Ms Mansi Shah Doshi
Medicines Optimisation Clinic
Chairing of 42 - Digital twins for medication therapy: Simulation for precision therapy
